Menu
x
About Biogenix
BioGenix is leading a new frontier in preventative and regenerative therapy.
Regenerative therapy has the potential for transforming healthcare through non-invasive procedures, and has made its way into clinical practice due to recent advances in biomedical science. Instead of targeting symptoms, regenerative therapy attempts to restore the structure and function of damaged tissues and cells from past injuries, chronic conditions, degenerative diseases and more. BioGenix advances this mission with the world's most advanced umbilical cord allograft products.
Check out our Lab
Hover over tiles for more information
Therapy Across Medical Specialities
Regenerative therapies are already available to physicians working in orthopedics, rheumatology, cardiology, neurology, and immunology, to name a few and their applications are growing.
WHAT IS REGENERATIVE THERAPY?
Commitment to Ethics, Safety, and Quality
BioGenix’s end-to-end supply chain protocol, and robust quality assurance standards, has culminated in the best safety record in the industry. Our products are made in our state-of-the-art FDA registered lab in accordance with cGMP, cGTP, AATB, and HCT/P guidelines
REGUALATORY & SAFTEY
Explore Key Studies in Cell Research
Regenerative research in vitro, in animal models, and in clinical studies have already covered broad ground -- and are always advancing. Read about the most important findings from peer reviewed studies.
REASERCH
INTERESTED IN LEARNING MORE?
We partner with clinicians and institutions all over the world, introducing them to the potential of regenerative therapy and show them how they can harness the power of the latest regenerative technology to improve patient care and their quality of life.
Research Topics
Pivotal Studies on Regenerative Medicine
Tissue Repair
Regenerative cells' ability to differentiate and secrete trophic factors has important potential for tissue regeneration and repair.Cell paracrine actions and tissue regeneration. Baranaki PR & McDevitt TC. Regenerative Medicine. 2010 Jan.
Arthritis
Regenerative medicine was found to produce improvement in a large study of patients with rheumatoid arthritis according to validated questionnaires. Human umbilical cell therapy for patients with active rheumatoid arthritis: safety and efficacy.Wang et al. Stem Cells Development. 2013 Dec.
Parkinson's
A study of Parkinson’s patients has demonstrated medium-term improvement with regenerative therapy.Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson-s disease. Venkataramana NK et al. Translational Research. 2010 Feb.
Organ Transplant
Stem cells have been shown to improve organ acceptance in kidney transplant.Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation. Perico N et al. Transplant International. 2013 Sep.